New Pill Box Possibilities; Super Monkey Moms; Science Seen

Front Page | New Pill Box Possibilities; Super Monkey Moms; Science Seen PhotoDisc GENE THERAPY | New Pill Box Possibilities "Take two genes and call me in the morning"--not exactly what one would expect a family doctor to say, but it could become a common prescription if a new "gene pill" pans out. James Hagstrom, vice president of Mirus, Madison, Wis., says "This technology would be extremely useful for wide ranging therapeutic applications." Hagstrom moderated a talk at the recent Kno

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

GENE THERAPY | New Pill Box Possibilities

"Take two genes and call me in the morning"--not exactly what one would expect a family doctor to say, but it could become a common prescription if a new "gene pill" pans out. James Hagstrom, vice president of Mirus, Madison, Wis., says "This technology would be extremely useful for wide ranging therapeutic applications." Hagstrom moderated a talk at the recent Knowledge Foundation conference.

To make a gene pill, researchers formulated DNA to survive the stomach's harsh environment and integrate into intestinal cells. Researcher David Olson, of Genteric, Alameda, Calif., which developed this new therapy, says that expression of a gene incorporated into intestinal cells would last about 10 days, because these cells undergo rapid turnover. Genteric showed that blood sugar dropped in diabetic mice that had received the human insulin gene via the gene pill.

Traditionally, such transient expression is a problem for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Mignon Fogarty

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours